MedXCell pipeline company CYTEA|BIO to attend the Jefferies Healthcare Conference in London (November 15-17, 2022)
Montreux, Switzerland | November 2, 2022 – CYTEA|BIO, a preclinical-stage biotechnology company focusing on allogeneic cellular immunotherapies combining non genetically modified effector cells (such as